文献速递核素与放射性配体治疗

基于SPECT/CT图像的深度Transformer个性化剂量学:[177Lu]Lu-DOTATATE放射药物治疗的混合方法

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-01-25

本研究纳入22例接受最多4个周期[177Lu]Lu-DOTATATE治疗的患者,开发了基于UNETR架构的混合Transformer深度学习模型,结合多体素S值(MSV)方法生成体素级剂量图,并与蒙特卡洛(MC)模拟参考及MIRD形式(SSV、MSV)进行定量比较。结果显示DL方法体素相对绝对误差(RAE)为5.28±1.32,略优于MSV(5.54±1.4)并优于SSV(7.8±3.02),计算时间仅3秒/单床位SPECT,远快于MC的约2天,作者认为该模型精度接近MC金标准,具有大规模数据集临床实施的潜力。

要点

  • DL模型体素RAE为5.28±1.32,略优于MSV的5.54±1.4并优于SSV的7.8±3.02。
  • DL、MSV、SSV的伽马分析通过率分别为99.0±1.2%、98.8±1.3%、98.7±1.52%。
  • DL方法单床位SPECT计算仅需3秒,MC约需2天,DL时间效率最优。

核心结论

  • 作者开发了基于Transformer的混合深度学习模型用于快速准确的剂量图生成,在异质性区域优于MIRD方法,精度接近MC金标准,具有大规模数据集临床实施的潜力。

研究设计与样本

  • 研究使用22例接受最多4个周期[177Lu]Lu-DOTATATE治疗的患者数据集,以MC模拟生成参考吸收剂量图。
  • 采用五折交叉验证训练UNETR深度学习架构,输入为配准CT图像,输出为MC与MSV之差(MC-MSV),再将DL结果与MSV整合重建MC剂量图。
  • 将MSV、SSV和DL生成的剂量图在体素水平和器官水平(危机器官与病灶)与MC参考进行定量比较。

主要发现

  • DL方法体素相对绝对误差(RAE)为5.28±1.32,略优于MSV(5.54±1.4),并优于SSV(7.8±3.02)。
  • DL、MSV、SSV的伽马分析通过率分别为99.0±1.2%、98.8±1.3%、98.7±1.52%。
  • MC计算时间最高(单床位SPECT研究约2天),DL方法时间效率优于其他方法(单床位SPECT仅3秒)。
  • 病灶吸收剂量器官水平绝对百分比误差:SSV为1.44±3.05%,MSV为1.18±2.65%,DL为1.15±2.5%。

临床怎么用

  • 作者认为该混合Transformer深度学习模型精度接近MC金标准,具有大规模数据集临床实施的潜力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accurate dosimetry is critical for ensuring the safety and efficacy of radiopharmaceutical therapies. In current clinical dosimetry practice, MIRD formalisms are widely employed. However, with the rapid advancement of deep learning (DL) algorithms, there has been an increasing interest in leveraging the calculation speed and automation capabilities for different tasks. We aimed to develop a hybrid transformer-based deep learning (DL) model that incorporates a multiple voxel S-value (MSV) approach for voxel-level dosimetry in [177Lu]Lu-DOTATATE therapy. The goal was to enhance the performance of the model to achieve accuracy levels closely aligned with Monte Carlo (MC) simulations, considered as the standard of reference. We extended our analysis to include MIRD formalisms (SSV and MSV), thereby conducting a comprehensive dosimetry study. METHODS: We used a dataset consisting of 22 patients undergoing up to 4 cycles of [177Lu]Lu-DOTATATE therapy. MC simulations were used to generate reference absorbed dose maps. In addition, MIRD formalism approaches, namely, single S-value (SSV) and MSV techniques, were performed. A UNEt TRansformer (UNETR) DL architecture was trained using five-fold cross-validation to generate MC-based dose maps. Co-registered CT images were fed into the network as input, whereas the difference between MC and MSV (MC-MSV) was set as output. DL results are then integrated to MSV to revive the MC dose maps. Finally, the dose maps generated by MSV, SSV, and DL were quantitatively compared to the MC reference at both voxel level and organ level (organs at risk and lesions). RESULTS: The DL approach showed slightly better performance (voxel relative absolute error (RAE) = 5.28 ± 1.32) compared to MSV (voxel RAE = 5.54 ± 1.4) and outperformed SSV (voxel RAE = 7.8 ± 3.02). Gamma analysis pass rates were 99.0 ± 1.2%, 98.8 ± 1.3%, and 98.7 ± 1.52% for DL, MSV, and SSV approaches, respectively. The computational time for MC was the highest (~2 days for a single-bed SPECT study) compared to MSV, SSV, and DL, whereas the DL-based approach outperformed the other approaches in terms of time efficiency (3 s for a single-bed SPECT). Organ-wise analysis showed absolute percent errors of 1.44 ± 3.05%, 1.18 ± 2.65%, and 1.15 ± 2.5% for SSV, MSV, and DL approaches, respectively, in lesion-absorbed doses. CONCLUSION: A hybrid transformer-based deep learning model was developed for fast and accurate dose map generation, outperforming the MIRD approaches, specifically in heterogenous regions. The model achieved accuracy close to MC gold standard and has potential for clinical implementation for use on large-scale datasets.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Mansouri Z, Salimi Y, Akhavanallaf A, et al. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy. Eur J Nucl Med Mol Imaging. 2024. PMID: 38267686. doi:10.1007/s00259-024-06618-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。